{"id":297,"date":"2021-07-06T16:41:03","date_gmt":"2021-07-06T16:41:03","guid":{"rendered":"https:\/\/ofmom.adhoc-digitale.it\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/"},"modified":"2022-02-11T08:28:02","modified_gmt":"2022-02-11T08:28:02","slug":"korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology","status":"publish","type":"post","link":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/","title":{"rendered":"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology"},"content":{"rendered":"<p>Korea National Institute of Health (KNIH), Korea\u2019s top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology.<\/p>\n<p>&nbsp;<\/p>\n<p>KNIH visited Hanmi Fine Chemical which is a company specializing in raw materials, which is a subsidiary of Hanmi Pharmaceutical Group and specializes in pharmaceutical products and conducted the verification of technical capability of Hanmi which recently succeeded in the synthesis of six types of mRNA core materials.<\/p>\n<p>&nbsp;<\/p>\n<p>Mr. Kwon confirmed the possibility of mass production of six type mRNA raw materials that Hanmi Fine Chemicals has been researching since the end of last year and has recently developed, and the potential as Korea\u2019s gene vaccine production hub, and Hanmi\u2019s continuous R&amp;D capabilities. He asked Hanmi to continue the research and development to help Korea secure national sovereignty in the production of vaccines.<\/p>\n<p>&nbsp;<\/p>\n<p>Lim Chong-Yoon, chairman of Korea Biotechnology Industry Organization (CEO of Hanmi Science), said, \u201cYes, we have the capability.\u201d, adding \u201cThough its monthly production may vary, Hanmi is the only company in Korea that has the ability of producing and supplying materials for 300 million doses within 12 months and Hanmi can rapidly supply the core materials of mRNA which is now in short of supply worldwide\u201d.<\/p>\n<p>&nbsp;<\/p>\n<p>Meanwhile, it was also confirmed that Hanmi Science is currently in the process of participating in the WHO\u2019s construction plan of the regional hub for worldwide vaccine supply. This is a project to establish a base of the mass production for a global vaccine supply through the WHO and COVAX as part of the \u201cKOREA-US Global Vaccine Partnership\u201d.<\/p>\n<p>&nbsp;<\/p>\n<p>In fact, WHO officially announced on the 21<sup>st<\/sup>\u00a0by referring South Africa as the first candidate for a vaccine hub, \u201cWe are in discussion to establish the first production base of COVID-19 mRNA vaccine in South Africa.\u201d Mr. Tedros Adhanom Ghebreyesus (WHO\u2019s Director-General) said in the press briefing \u201cthis is especially good news for Africa where has suffered from the lack of vaccine.\u201d<\/p>\n<p>&nbsp;<\/p>\n<p>Chairman Lim Chong-Yoon mentioned, \u201cWe will have to wait for the final conclusion, but it should be noted that the WHO is seriously considering the potential of Korea as a global vaccine hub.\u201d<\/p>\n<p>&nbsp;<\/p>\n<p>On the 21st, the White House also announced plans for a global vaccine supply, saying that \u201c1 billion doses of vaccine will be produced in 2021 and 2022 in Africa and India.\u201d In addition, the Korean government said at the G7 summit held in the UK on the 13th that \u201cKorea will contribute 100 million US dollars to the Covid-19 Vaccines Advance Market Commitment (AMC) this year.\u201d<\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-85\" src=\"\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita.jpg\" alt=\"Director Jun-wook Kwon of the National Institute of Health\" width=\"1134\" height=\"686\" srcset=\"https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita.jpg 1134w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita-800x484.jpg 800w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita-300x181.jpg 300w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita-1024x619.jpg 1024w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita-768x465.jpg 768w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita-241x146.jpg 241w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita-50x30.jpg 50w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita-124x75.jpg 124w\" sizes=\"(max-width:767px) 480px, (max-width:1134px) 100vw, 1134px\" \/><\/p>\n<p><em><strong>Photo:<\/strong>\u00a0Director Jun-wook Kwon (center) of the National Institute of Health is conducting on-site verification of the mRNA raw material production process accumulated by Hanmi with officials of Hanmi Pharmaceutical Group.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-88\" src=\"\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita2.jpg\" alt=\"Director Jun-wook Kwon of the National Institute of Health\" width=\"1134\" height=\"714\" srcset=\"https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita2.jpg 1134w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita2-800x504.jpg 800w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita2-300x189.jpg 300w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita2-1024x645.jpg 1024w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita2-768x484.jpg 768w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita2-232x146.jpg 232w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita2-50x31.jpg 50w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Il-direttore-Jun-Wook-Kwon_al-centro_dellIstituto-Nazionale-della-Sanita2-119x75.jpg 119w\" sizes=\"(max-width:767px) 480px, (max-width:1134px) 100vw, 1134px\" \/><\/p>\n<p><em><strong>Photo:<\/strong>\u00a0Director Jun-wook Kwon (center) of the National Institute of Health is conducting on-site verification of the mRNA raw material production process accumulated by Hanmi with officials of Hanmi Pharmaceutical Group.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignnone size-full wp-image-90\" src=\"\/wp-content\/uploads\/2021\/07\/Young-Gil-Jang-a-sinistra_CEO-di-Hanmi-Fine-Chemicals-a-sinistra-e-Chong-Yoon-Lim_CEO-Hanmi-Science-al-centro.jpg\" alt=\"oung-gil Jang (left), CEO of Hanmi Fine Chemicals (left) and Jong-yoon Lim (CEO, Hanmi Science, middle), chairman of the Korea Biotechnology Association (CEO, Hanmi Science, middle)\" width=\"1134\" height=\"731\" srcset=\"https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Young-Gil-Jang-a-sinistra_CEO-di-Hanmi-Fine-Chemicals-a-sinistra-e-Chong-Yoon-Lim_CEO-Hanmi-Science-al-centro.jpg 1134w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Young-Gil-Jang-a-sinistra_CEO-di-Hanmi-Fine-Chemicals-a-sinistra-e-Chong-Yoon-Lim_CEO-Hanmi-Science-al-centro-800x516.jpg 800w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Young-Gil-Jang-a-sinistra_CEO-di-Hanmi-Fine-Chemicals-a-sinistra-e-Chong-Yoon-Lim_CEO-Hanmi-Science-al-centro-300x193.jpg 300w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Young-Gil-Jang-a-sinistra_CEO-di-Hanmi-Fine-Chemicals-a-sinistra-e-Chong-Yoon-Lim_CEO-Hanmi-Science-al-centro-1024x660.jpg 1024w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Young-Gil-Jang-a-sinistra_CEO-di-Hanmi-Fine-Chemicals-a-sinistra-e-Chong-Yoon-Lim_CEO-Hanmi-Science-al-centro-768x495.jpg 768w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Young-Gil-Jang-a-sinistra_CEO-di-Hanmi-Fine-Chemicals-a-sinistra-e-Chong-Yoon-Lim_CEO-Hanmi-Science-al-centro-226x146.jpg 226w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Young-Gil-Jang-a-sinistra_CEO-di-Hanmi-Fine-Chemicals-a-sinistra-e-Chong-Yoon-Lim_CEO-Hanmi-Science-al-centro-50x32.jpg 50w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/Young-Gil-Jang-a-sinistra_CEO-di-Hanmi-Fine-Chemicals-a-sinistra-e-Chong-Yoon-Lim_CEO-Hanmi-Science-al-centro-116x75.jpg 116w\" sizes=\"(max-width:767px) 480px, (max-width:1134px) 100vw, 1134px\" \/><\/p>\n<p><em><strong>Photo:<\/strong>\u00a0Young-gil Jang (left), CEO of Hanmi Fine Chemicals (left) and Jong-yoon Lim (CEO, Hanmi Science, middle), chairman of the Korea Biotechnology Association (CEO, Hanmi Science, middle), told the National Institute of Health Kwon Jun-wook (right) about the nucleic acid raw materials for mRNA vaccines secured by Hanmi and the production process of nano lipid particles. is explaining.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-91 size-full\" src=\"\/wp-content\/uploads\/2021\/07\/I-funzionari-dellIstituto-Nazionale-della-Salute-e-della-Hanmi-Pharmaceutical.jpg\" alt=\"Officials from the National Institute of Health and Hanmi Pharmaceutical\" width=\"1322\" height=\"796\" srcset=\"https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/I-funzionari-dellIstituto-Nazionale-della-Salute-e-della-Hanmi-Pharmaceutical.jpg 1322w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/I-funzionari-dellIstituto-Nazionale-della-Salute-e-della-Hanmi-Pharmaceutical-800x482.jpg 800w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/I-funzionari-dellIstituto-Nazionale-della-Salute-e-della-Hanmi-Pharmaceutical-300x181.jpg 300w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/I-funzionari-dellIstituto-Nazionale-della-Salute-e-della-Hanmi-Pharmaceutical-1024x617.jpg 1024w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/I-funzionari-dellIstituto-Nazionale-della-Salute-e-della-Hanmi-Pharmaceutical-768x462.jpg 768w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/I-funzionari-dellIstituto-Nazionale-della-Salute-e-della-Hanmi-Pharmaceutical-242x146.jpg 242w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/I-funzionari-dellIstituto-Nazionale-della-Salute-e-della-Hanmi-Pharmaceutical-50x30.jpg 50w, https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/07\/I-funzionari-dellIstituto-Nazionale-della-Salute-e-della-Hanmi-Pharmaceutical-125x75.jpg 125w\" sizes=\"(max-width:767px) 480px, (max-width:1322px) 100vw, 1322px\" \/><\/p>\n<p><em><strong>Photo:<\/strong>\u00a0Officials from the National Institute of Health and Hanmi Pharmaceutical are taking a commemorative photo after the field inspection. (From left) Managing Director Kwon Gyu-Chan of Hanmi Pharmaceutical, Su-Jin Kim, Managing Director of Hanmi Fine Chemicals Young-Gil Jang, Chairman Lim Jong-Yun of Korea Bio Association (CEO of Hanmi Science), Joon-Wook Kwon of the National Institute of Health, Do-Geun Kim, Manager Kim Do-Geun, Director Lee Jae-Yun, Director Kim Jang-Hee of Hanmi Science.<\/em><\/p>\n<p>&nbsp;<\/p>\n<p>Source: The Wall Street Journal<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Korea National Institute of Health (KNIH), Korea\u2019s top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology. &nbsp; KNIH visited Hanmi Fine Chemical which is a company specializing in raw materials, which is a subsidiary of Hanmi Pharmaceutical Group and specializes in pharmaceutical products<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[23],"tags":[],"class_list":["post-297","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology - Ofmom<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology - Ofmom\" \/>\n<meta property=\"og:description\" content=\"Korea National Institute of Health (KNIH), Korea\u2019s top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology. &nbsp; KNIH visited Hanmi Fine Chemical which is a company specializing in raw materials, which is a subsidiary of Hanmi Pharmaceutical Group and specializes in pharmaceutical products [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/\" \/>\n<meta property=\"og:site_name\" content=\"Ofmom\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ofmomitalia\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-06T16:41:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-11T08:28:02+00:00\" \/>\n<meta name=\"author\" content=\"Ofmom\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ofmom\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/\"},\"author\":{\"name\":\"Ofmom\",\"@id\":\"https:\/\/www.ofmom.it\/en\/#\/schema\/person\/49f3f1229376b5b239d7f7f851949258\"},\"headline\":\"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology\",\"datePublished\":\"2021-07-06T16:41:03+00:00\",\"dateModified\":\"2022-02-11T08:28:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/\"},\"wordCount\":657,\"publisher\":{\"@id\":\"https:\/\/www.ofmom.it\/en\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/\",\"url\":\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/\",\"name\":\"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology - Ofmom\",\"isPartOf\":{\"@id\":\"https:\/\/www.ofmom.it\/en\/#website\"},\"datePublished\":\"2021-07-06T16:41:03+00:00\",\"dateModified\":\"2022-02-11T08:28:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ofmom.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ofmom.it\/en\/#website\",\"url\":\"https:\/\/www.ofmom.it\/en\/\",\"name\":\"Ofmom\",\"description\":\"For the health of a mother and a child\",\"publisher\":{\"@id\":\"https:\/\/www.ofmom.it\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ofmom.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ofmom.it\/en\/#organization\",\"name\":\"Ofmom\",\"url\":\"https:\/\/www.ofmom.it\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ofmom.it\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/11\/ofmom-logo.png\",\"contentUrl\":\"https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/11\/ofmom-logo.png\",\"width\":344,\"height\":140,\"caption\":\"Ofmom\"},\"image\":{\"@id\":\"https:\/\/www.ofmom.it\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ofmomitalia\",\"https:\/\/www.instagram.com\/ofmom_italia\/\",\"https:\/\/www.linkedin.com\/company\/coree-italy\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ofmom.it\/en\/#\/schema\/person\/49f3f1229376b5b239d7f7f851949258\",\"name\":\"Ofmom\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ofmom.it\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/411a0af965b150eb912d95b674f19a39edae33fa8885a8f6b52b9eb5b3858261?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/411a0af965b150eb912d95b674f19a39edae33fa8885a8f6b52b9eb5b3858261?s=96&d=mm&r=g\",\"caption\":\"Ofmom\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology - Ofmom","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/","og_locale":"en_US","og_type":"article","og_title":"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology - Ofmom","og_description":"Korea National Institute of Health (KNIH), Korea\u2019s top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology. &nbsp; KNIH visited Hanmi Fine Chemical which is a company specializing in raw materials, which is a subsidiary of Hanmi Pharmaceutical Group and specializes in pharmaceutical products [\u2026]","og_url":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/","og_site_name":"Ofmom","article_publisher":"https:\/\/www.facebook.com\/ofmomitalia","article_published_time":"2021-07-06T16:41:03+00:00","article_modified_time":"2022-02-11T08:28:02+00:00","author":"Ofmom","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ofmom","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/#article","isPartOf":{"@id":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/"},"author":{"name":"Ofmom","@id":"https:\/\/www.ofmom.it\/en\/#\/schema\/person\/49f3f1229376b5b239d7f7f851949258"},"headline":"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology","datePublished":"2021-07-06T16:41:03+00:00","dateModified":"2022-02-11T08:28:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/"},"wordCount":657,"publisher":{"@id":"https:\/\/www.ofmom.it\/en\/#organization"},"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/","url":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/","name":"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology - Ofmom","isPartOf":{"@id":"https:\/\/www.ofmom.it\/en\/#website"},"datePublished":"2021-07-06T16:41:03+00:00","dateModified":"2022-02-11T08:28:02+00:00","breadcrumb":{"@id":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ofmom.it\/en\/korea-national-institute-of-health-knih-conducts-field-inspection-of-companies-with-mrna-technology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ofmom.it\/en\/"},{"@type":"ListItem","position":2,"name":"Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology"}]},{"@type":"WebSite","@id":"https:\/\/www.ofmom.it\/en\/#website","url":"https:\/\/www.ofmom.it\/en\/","name":"Ofmom","description":"For the health of a mother and a child","publisher":{"@id":"https:\/\/www.ofmom.it\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ofmom.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ofmom.it\/en\/#organization","name":"Ofmom","url":"https:\/\/www.ofmom.it\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ofmom.it\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/11\/ofmom-logo.png","contentUrl":"https:\/\/www.ofmom.it\/wp-content\/uploads\/2021\/11\/ofmom-logo.png","width":344,"height":140,"caption":"Ofmom"},"image":{"@id":"https:\/\/www.ofmom.it\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ofmomitalia","https:\/\/www.instagram.com\/ofmom_italia\/","https:\/\/www.linkedin.com\/company\/coree-italy\/"]},{"@type":"Person","@id":"https:\/\/www.ofmom.it\/en\/#\/schema\/person\/49f3f1229376b5b239d7f7f851949258","name":"Ofmom","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ofmom.it\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/411a0af965b150eb912d95b674f19a39edae33fa8885a8f6b52b9eb5b3858261?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/411a0af965b150eb912d95b674f19a39edae33fa8885a8f6b52b9eb5b3858261?s=96&d=mm&r=g","caption":"Ofmom"}}]}},"_links":{"self":[{"href":"https:\/\/www.ofmom.it\/en\/wp-json\/wp\/v2\/posts\/297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ofmom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ofmom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ofmom.it\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ofmom.it\/en\/wp-json\/wp\/v2\/comments?post=297"}],"version-history":[{"count":0,"href":"https:\/\/www.ofmom.it\/en\/wp-json\/wp\/v2\/posts\/297\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ofmom.it\/en\/wp-json\/wp\/v2\/media?parent=297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ofmom.it\/en\/wp-json\/wp\/v2\/categories?post=297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ofmom.it\/en\/wp-json\/wp\/v2\/tags?post=297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}